-
FTC resolves Express Scripts case with ‘landmark settlement’
The pharmacy benefits manager has copped to artificially inflating the list price of drugs by using unfair rebating practices.
-
Former Seahawks tight end convicted in $200m healthcare fraud scheme
Joel Rufus French pressured elderly Americans to provide their personal and health insurance information and accept unnecessary orthotic braces.
-
FDA launches program to bolster domestic drug manufacturing
The PreCheck program aims to make it significantly less onerous to set up domestic manufacturing plants provided they align with US national priorities.
-
CMS proposes financial incentives for hospitals to buy American supplies
The proposed rule change appears to be an acknowledgement that shifting supply chains to domestic manufacturers would significantly strain hospital operating margins.
-
CMS proposes flat rates for 2027 Medicare Advantage to ensure ‘sustainability’
The agency is also proposing a shift in the risk-adjustment model traditionally used in the MA program.
-
SEC settles insider trading case with Massachusetts resident involving Sage Therapeutics
The agency alleged that Brian Suthoff liquidated all of his Sage stock in advance of negative news.
-
FDA issues warning letters to four companies for sale of HIV self-collection blood tests
The federal regulator contends the four biologics firms lack appropriate testing and marketing authorization.
-
AMA survey reveals state health policy priorities and challenges
The survey of the 64 physician organizations spotlights their leading healthcare priorities, defining the state-level legislative – and risk – landscape in 2026.